Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy.
Saved in:
| Title: | Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy. |
|---|---|
| Authors: | Vogel, Marco M. E.1,2 (AUTHOR) marco.vogel@tum.de, Kroeze, Stephanie G. C.3 (AUTHOR), Henkenberens, Christoph4 (AUTHOR), Schmidt-Hegemann, Nina-Sophie5 (AUTHOR), Kirste, Simon6,7 (AUTHOR), Becker, Jessica8 (AUTHOR), Burger, Irene A.9 (AUTHOR), Derlin, Thorsten10 (AUTHOR), Bartenstein, Peter11 (AUTHOR), Mix, Michael12 (AUTHOR), la Fougère, Christian13,14,15 (AUTHOR), Eiber, Matthias16 (AUTHOR), Christiansen, Hans4 (AUTHOR), Belka, Claus5,17 (AUTHOR), Grosu, Anca L.6,7 (AUTHOR), Müller, Arndt-Christian8 (AUTHOR), Guckenberger, Matthias3 (AUTHOR), Combs, Stephanie E.1,2,17 (AUTHOR) |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Sep2020, Vol. 47 Issue 10, p2328-2338. 11p. 2 Diagrams, 6 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
